[UOADEV] QoQ TTM Result on 30-Sep-2016 [#3]

Stock
[UOADEV] UOA DEVELOPMENT BERHAD
Announcement Date
23-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -9.82%
YoY- 12.04%
Quarter Report
Latest QR
Upcoming QR
UOADEV's Result
UOADEV's Financial Summary
View:
Show?
TTM Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,120,912 949,624 996,193 1,237,148 1,499,756 1,530,659 1,643,188 -22.52%
PBT 914,090 874,891 929,364 641,039 729,579 656,507 645,286 26.15%
Tax -223,292 -205,486 -218,726 -140,497 -172,216 -161,206 -157,253 26.35%
NP 690,798 669,405 710,638 500,542 557,363 495,301 488,033 26.09%
-
NP to SH 665,449 629,627 676,726 441,814 489,908 434,612 417,016 36.59%
-
Tax Rate 24.43% 23.49% 23.54% 21.92% 23.60% 24.56% 24.37% -
Total Cost 430,114 280,219 285,555 736,606 942,393 1,035,358 1,155,155 -48.27%
-
Net Worth 3,786,308 3,261,278 3,817,347 3,434,244 3,147,438 3,253,274 3,145,125 13.17%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 244,701 244,701 244,701 227,907 227,907 227,907 227,907 4.85%
Div Payout % 36.77% 38.86% 36.16% 51.58% 46.52% 52.44% 54.65% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 3,786,308 3,261,278 3,817,347 3,434,244 3,147,438 3,253,274 3,145,125 13.17%
NOSH 1,632,029 1,630,639 1,632,469 1,612,321 1,520,501 1,520,221 1,519,384 4.88%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 61.63% 70.49% 71.34% 40.46% 37.16% 32.36% 29.70% -
ROE 17.58% 19.31% 17.73% 12.86% 15.57% 13.36% 13.26% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 68.68 58.24 61.07 76.73 98.64 100.69 108.15 -26.13%
EPS 40.77 38.61 41.48 27.40 32.22 28.59 27.45 30.20%
DPS 15.00 15.01 15.00 14.14 15.00 14.99 15.00 0.00%
NAPS 2.32 2.00 2.34 2.13 2.07 2.14 2.07 7.90%
Adjusted Per Share Value based on latest NOSH - 1,612,321
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 42.70 36.18 37.95 47.13 57.14 58.31 62.60 -22.52%
EPS 25.35 23.99 25.78 16.83 18.66 16.56 15.89 36.57%
DPS 9.32 9.32 9.32 8.68 8.68 8.68 8.68 4.86%
NAPS 1.4424 1.2424 1.4543 1.3083 1.1991 1.2394 1.1982 13.17%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 2.55 2.70 2.35 2.50 2.19 2.12 2.06 -
P/RPS 3.71 4.64 3.85 3.26 2.22 2.11 1.90 56.28%
P/EPS 6.25 6.99 5.67 9.12 6.80 7.42 7.51 -11.53%
EY 15.99 14.30 17.65 10.96 14.71 13.49 13.32 12.96%
DY 5.88 5.56 6.38 5.65 6.85 7.07 7.28 -13.28%
P/NAPS 1.10 1.35 1.00 1.17 1.06 0.99 1.00 6.56%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 23/08/17 22/05/17 22/02/17 23/11/16 24/08/16 25/05/16 25/02/16 -
Price 2.57 2.73 2.55 2.37 2.39 2.21 2.10 -
P/RPS 3.74 4.69 4.18 3.09 2.42 2.19 1.94 54.96%
P/EPS 6.30 7.07 6.15 8.65 7.42 7.73 7.65 -12.15%
EY 15.87 14.14 16.27 11.56 13.48 12.94 13.07 13.82%
DY 5.84 5.50 5.88 5.96 6.28 6.78 7.14 -12.55%
P/NAPS 1.11 1.37 1.09 1.11 1.15 1.03 1.01 6.50%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment